<DOC>
	<DOCNO>NCT00538148</DOCNO>
	<brief_summary>Non-inferiority efficacy telithromycin versus azithromycin</brief_summary>
	<brief_title>Telithromycin : Treatment Acute Exacerbation Chronic Bronchitis Adult Outpatients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Adult outpatient , either sex , age 45 year old . Patients document history chronic bronchitis basal FEV1 &lt; 70 % &gt; 35 % make previous 12 month least one AEBC previous year FEV1/FVC &lt; 70 % ( lung function test make previous 12 month ) . Patients clinical diagnosis acute exacerbation chronic bronchitis presumably due bacterial infection base follow sign symptom AECB : increase sputum purulence , least 1 2 follow sign symptom ( increased dyspnea , increase sputum volume ) . Patients negative chest radiography ( posterior/anterior lateral view ) rule pneumonia within 48 hour initiation study medication late 24 hour initiation study medication ( necessary include patient pneumonia associate AECB ) . Patients sputum specimen collect inclusion gram stain bacteriological culture . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>